Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
The Malaysian Journal of Pathology ; : 203-207, 2018.
Article in English | WPRIM | ID: wpr-750369

ABSTRACT

@#Introduction: Primary uterine angiosarcoma is a very rare tumour, with only 23 cases described till now. It is a malignant tumour with cells variably recapitulating the morphologic features of an endothelium and expressing immunohistochemical markers of endothelial cells. In general, it is a bulky neoplasm and frequently is at advance stage of disease at presentation. In general, patients with uterine angiosarcoma tend to have a poorer prognosis, mostly related to the aggressive nature and the metastatic potential of these tumours. Case report: We report a rare case of primary uterine angiosarcoma with unusual rhabdoid morphology in a 41-year-old female, who underwent radical hysterectomy and died of disease after 4 months of treatment. Discussion: We described the differential diagnosis of primary angiosarcoma of the uterus that can pose a diagnostic challenge.


Subject(s)
Hemangiosarcoma
2.
Hamdard Medicus. 2008; 51 (3): 5-12
in English | IMEMR | ID: emr-102197

ABSTRACT

During past few years identification of many molecules that participate in neuronal death and particularly apoptosis by various experimental studies, has contributed to the information on pathogenesis of ischemic brain injury and oxidative stress has been regarded as one of the mechanisms. The present study has been undertaken to evaluate a free radical, as a measure of lipid peroxidation in patients with cerebral infarction and haemorrhage and also to correlate its level with lesion size and its outcome in the patient. The study included 50 patients of stroke [25 each with infarction and haemorrhage] while 25 comparable subjects served as control. Serum malondialdehyde [SMDA] levels was estimated on the first day of admission in both the study groups as a measure of lipid peroxidation status in these subjects and the lesion size was measured by computed tomography. The mean SMDA level in thrombotic and haemorrhagic group was 4.16 +/- 0.04 nmol/dL and 4.03 +/- 1.1 nmol/dL while it was 1.9 +/- 0.4 nmol/dL in control. The difference in the mean SMDA levels in the controls and study subjects were statistically significant [p<0.001], while the difference between the thrombotic and haemorrhagic groups was statistically insignificant. The mean size of large lesion in thrombotic group was 13.6 +/- 3.0 cm[2] while it was 5.0 +/- 1.4 cm[2] for small lesions. The corresponding values of SMDA with these lesions were 4.98 +/- 0.9 nmol/dL and 3.23 +/- 0.4 nmol/dL. In haemorrhagic group mean size of large lesion was 13.3 +/- 1.9 cm[2] while that of small lesion was 6.6 +/- 1.9 cm[2]. The respective SMDA levels were 5.0 +/- 0.7 nmol/dL and 3.13 +/- 0.2 nmol/dL. There was marked statistical significance [p<0.001] in the SMDA levels between the small and large lesions in both study groups. A significant correlation existed between serum MDA levels, lesion size and early outcome in patients with stroke [p<0.001]. It is, therefore, concluded that the SMDA levels are raised in patients with acute stroke and hence are an indicator of the involvement of lipid peroxidation in its pathophysiology and can also be used as a prognostic markers in subjects with stroke


Subject(s)
Humans , Malondialdehyde/blood , Brain Ischemia/pathology , Stroke/physiopathology , Oxidative Stress , Lipid Peroxides/blood , Biomarkers
SELECTION OF CITATIONS
SEARCH DETAIL